The global Dry Eye Syndrome Drugs market was valued at US$ 5540.9 million in 2022 and is projected to reach US$ 6933 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Syndrome Drugs. This report contains market size and forecasts of Dry Eye Syndrome Drugs in global, including the following market information:
- Global Dry Eye Syndrome Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.
In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
We surveyed the Dry Eye Syndrome Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Eye Syndrome Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Dry Eye Syndrome Drugs Market Segment Percentages, by Type, 2022 (%)
- Antibiotic Drops
- Hormone Drops
- Artificial Tears
Global Dry Eye Syndrome Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Dry Eye Syndrome Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics
- Household Use
Global Dry Eye Syndrome Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Dry Eye Syndrome Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Eye Syndrome Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dry Eye Syndrome Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Allergan
- Novartis
- Santen
- Takeda
- Otsuka
- Eyegate Pharma
- Can-Fite BioPharma
- Bausch and Lomb
- Auven Therapeutics (Celtic)
- Bridge Pharma
- Cellzome
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Dry Eye Syndrome Drugs, market overview.
- Chapter 2: Global Dry Eye Syndrome Drugs market size in revenue.
- Chapter 3: Detailed analysis of Dry Eye Syndrome Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Dry Eye Syndrome Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dry Eye Syndrome Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dry Eye Syndrome Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dry Eye Syndrome Drugs Overall Market Size
2.1 Global Dry Eye Syndrome Drugs Market Size: 2022 VS 2032
2.2 Global Dry Eye Syndrome Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dry Eye Syndrome Drugs Players in Global Market
3.2 Top Global Dry Eye Syndrome Drugs Companies Ranked by Revenue
3.3 Global Dry Eye Syndrome Drugs Revenue by Companies
3.4 Top 3 and Top 5 Dry Eye Syndrome Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Dry Eye Syndrome Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dry Eye Syndrome Drugs Players in Global Market
3.6.1 List of Global Tier 1 Dry Eye Syndrome Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Dry Eye Syndrome Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dry Eye Syndrome Drugs Market Size Markets, 2022 & 2032
4.1.2 Antibiotic Drops
4.1.3 Hormone Drops
4.1.4 Artificial Tears
4.2 By Type - Global Dry Eye Syndrome Drugs Revenue & Forecasts
4.2.1 By Type - Global Dry Eye Syndrome Drugs Revenue, 2018-2023
4.2.2 By Type - Global Dry Eye Syndrome Drugs Revenue, 2024-2032
4.2.3 By Type - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dry Eye Syndrome Drugs Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Household Use
5.2 By Application - Global Dry Eye Syndrome Drugs Revenue & Forecasts
5.2.1 By Application - Global Dry Eye Syndrome Drugs Revenue, 2018-2023
5.2.2 By Application - Global Dry Eye Syndrome Drugs Revenue, 2024-2032
5.2.3 By Application - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Dry Eye Syndrome Drugs Market Size, 2022 & 2032
6.2 By Region - Global Dry Eye Syndrome Drugs Revenue & Forecasts
6.2.1 By Region - Global Dry Eye Syndrome Drugs Revenue, 2018-2023
6.2.2 By Region - Global Dry Eye Syndrome Drugs Revenue, 2024-2032
6.2.3 By Region - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Dry Eye Syndrome Drugs Revenue, 2018-2032
6.3.2 US Dry Eye Syndrome Drugs Market Size, 2018-2032
6.3.3 Canada Dry Eye Syndrome Drugs Market Size, 2018-2032
6.3.4 Mexico Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Dry Eye Syndrome Drugs Revenue, 2018-2032
6.4.2 Germany Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4.3 France Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4.4 U.K. Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4.5 Italy Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4.6 Russia Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Dry Eye Syndrome Drugs Market Size, 2018-2032
6.4.8 Benelux Dry Eye Syndrome Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Dry Eye Syndrome Drugs Revenue, 2018-2032
6.5.2 China Dry Eye Syndrome Drugs Market Size, 2018-2032
6.5.3 Japan Dry Eye Syndrome Drugs Market Size, 2018-2032
6.5.4 South Korea Dry Eye Syndrome Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Dry Eye Syndrome Drugs Market Size, 2018-2032
6.5.6 India Dry Eye Syndrome Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Dry Eye Syndrome Drugs Revenue, 2018-2032
6.6.2 Brazil Dry Eye Syndrome Drugs Market Size, 2018-2032
6.6.3 Argentina Dry Eye Syndrome Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dry Eye Syndrome Drugs Revenue, 2018-2032
6.7.2 Turkey Dry Eye Syndrome Drugs Market Size, 2018-2032
6.7.3 Israel Dry Eye Syndrome Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Dry Eye Syndrome Drugs Market Size, 2018-2032
6.7.5 UAE Dry Eye Syndrome Drugs Market Size, 2018-2032
7 Dry Eye Syndrome Drugs Companies Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Dry Eye Syndrome Drugs Major Product Offerings
7.1.4 Allergan Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Dry Eye Syndrome Drugs Major Product Offerings
7.2.4 Novartis Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Santen
7.3.1 Santen Company Summary
7.3.2 Santen Business Overview
7.3.3 Santen Dry Eye Syndrome Drugs Major Product Offerings
7.3.4 Santen Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.3.5 Santen Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Dry Eye Syndrome Drugs Major Product Offerings
7.4.4 Takeda Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 Otsuka
7.5.1 Otsuka Company Summary
7.5.2 Otsuka Business Overview
7.5.3 Otsuka Dry Eye Syndrome Drugs Major Product Offerings
7.5.4 Otsuka Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.5.5 Otsuka Key News & Latest Developments
7.6 Eyegate Pharma
7.6.1 Eyegate Pharma Company Summary
7.6.2 Eyegate Pharma Business Overview
7.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Major Product Offerings
7.6.4 Eyegate Pharma Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.6.5 Eyegate Pharma Key News & Latest Developments
7.7 Can-Fite BioPharma
7.7.1 Can-Fite BioPharma Company Summary
7.7.2 Can-Fite BioPharma Business Overview
7.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Major Product Offerings
7.7.4 Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.7.5 Can-Fite BioPharma Key News & Latest Developments
7.8 Bausch and Lomb
7.8.1 Bausch and Lomb Company Summary
7.8.2 Bausch and Lomb Business Overview
7.8.3 Bausch and Lomb Dry Eye Syndrome Drugs Major Product Offerings
7.8.4 Bausch and Lomb Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.8.5 Bausch and Lomb Key News & Latest Developments
7.9 Auven Therapeutics (Celtic)
7.9.1 Auven Therapeutics (Celtic) Company Summary
7.9.2 Auven Therapeutics (Celtic) Business Overview
7.9.3 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Major Product Offerings
7.9.4 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.9.5 Auven Therapeutics (Celtic) Key News & Latest Developments
7.10 Bridge Pharma
7.10.1 Bridge Pharma Company Summary
7.10.2 Bridge Pharma Business Overview
7.10.3 Bridge Pharma Dry Eye Syndrome Drugs Major Product Offerings
7.10.4 Bridge Pharma Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.10.5 Bridge Pharma Key News & Latest Developments
7.11 Cellzome
7.11.1 Cellzome Company Summary
7.11.2 Cellzome Business Overview
7.11.3 Cellzome Dry Eye Syndrome Drugs Major Product Offerings
7.11.4 Cellzome Dry Eye Syndrome Drugs Revenue in Global Market (2018-2023)
7.11.5 Cellzome Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dry Eye Syndrome Drugs Market Opportunities & Trends in Global Market
Table 2. Dry Eye Syndrome Drugs Market Drivers in Global Market
Table 3. Dry Eye Syndrome Drugs Market Restraints in Global Market
Table 4. Key Players of Dry Eye Syndrome Drugs in Global Market
Table 5. Top Dry Eye Syndrome Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Dry Eye Syndrome Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Dry Eye Syndrome Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Dry Eye Syndrome Drugs Product Type
Table 9. List of Global Tier 1 Dry Eye Syndrome Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dry Eye Syndrome Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Dry Eye Syndrome Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Dry Eye Syndrome Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Dry Eye Syndrome Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Dry Eye Syndrome Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Dry Eye Syndrome Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Dry Eye Syndrome Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Allergan Company Summary
Table 31. Allergan Dry Eye Syndrome Drugs Product Offerings
Table 32. Allergan Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Allergan Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Dry Eye Syndrome Drugs Product Offerings
Table 36. Novartis Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Santen Company Summary
Table 39. Santen Dry Eye Syndrome Drugs Product Offerings
Table 40. Santen Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Santen Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Dry Eye Syndrome Drugs Product Offerings
Table 44. Takeda Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. Otsuka Company Summary
Table 47. Otsuka Dry Eye Syndrome Drugs Product Offerings
Table 48. Otsuka Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Otsuka Key News & Latest Developments
Table 50. Eyegate Pharma Company Summary
Table 51. Eyegate Pharma Dry Eye Syndrome Drugs Product Offerings
Table 52. Eyegate Pharma Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Eyegate Pharma Key News & Latest Developments
Table 54. Can-Fite BioPharma Company Summary
Table 55. Can-Fite BioPharma Dry Eye Syndrome Drugs Product Offerings
Table 56. Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Can-Fite BioPharma Key News & Latest Developments
Table 58. Bausch and Lomb Company Summary
Table 59. Bausch and Lomb Dry Eye Syndrome Drugs Product Offerings
Table 60. Bausch and Lomb Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bausch and Lomb Key News & Latest Developments
Table 62. Auven Therapeutics (Celtic) Company Summary
Table 63. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Product Offerings
Table 64. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Auven Therapeutics (Celtic) Key News & Latest Developments
Table 66. Bridge Pharma Company Summary
Table 67. Bridge Pharma Dry Eye Syndrome Drugs Product Offerings
Table 68. Bridge Pharma Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Bridge Pharma Key News & Latest Developments
Table 70. Cellzome Company Summary
Table 71. Cellzome Dry Eye Syndrome Drugs Product Offerings
Table 72. Cellzome Dry Eye Syndrome Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Cellzome Key News & Latest Developments
List of Figures
Figure 1. Dry Eye Syndrome Drugs Segment by Type in 2022
Figure 2. Dry Eye Syndrome Drugs Segment by Application in 2022
Figure 3. Global Dry Eye Syndrome Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dry Eye Syndrome Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Dry Eye Syndrome Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2022
Figure 8. By Type - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 16. US Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 28. China Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Dry Eye Syndrome Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Dry Eye Syndrome Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Allergan Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Santen Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Otsuka Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eyegate Pharma Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Can-Fite BioPharma Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bausch and Lomb Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bridge Pharma Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cellzome Dry Eye Syndrome Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
